Clinical Development Partnerships
Releasing the untapped potential in cancer drug development
Clinical Development Partnerships (CDP) is a joint initiative launched by Cancer Research UK in collaboration with its development and commercialisation company Cancer Research Technology Limited, to increase the number of clinical trials being undertaken for the treatment of cancer.
Cancer Research UK has a wealth of experience in early clinical development and aims to increase the number of promising novel-anti-cancer therapeutic agents under development. CDP is central to this objective and provides a simple route for companies to progress oncology agents that would not otherwise be developed.
- Cancer Research UK takes investigational multi-cancer drug from laboratory into unique trial
- Cancer Research UK's Drug Development Office (DDO) and AstraZeneca have opened a new trial of a drug called AZD0424....
- 18 Jan 2013